{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:04:29Z","timestamp":1792073069656,"version":"4.4.0"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00192","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T04:18:25Z","timestamp":1587097105000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART\/IVF?"],"prefix":"10.3389","volume":"11","author":[{"given":"Zeev","family":"Blumenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1586\/eog.11.15","article-title":"Fertility treatment in women with premature ovarian failure","volume":"6","author":"Blumenfeld","year":"2011","journal-title":"Expert Rev Obstet Gynecol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1586\/17446651.4.2.173","article-title":"Premature ovarian failure: etiology and possible prevention","volume":"4","author":"Blumenfeld","year":"2009","journal-title":"Expert Rev Endocrinol Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0015-0282(16)55854-3","article-title":"Premature ovarian failure\u2013the prognostic application of autoimmunity on conception after ovulation induction","volume":"59","author":"Blumenfeld","year":"1993","journal-title":"Fertil Steril."},{"key":"B4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1210\/edrv.18.1.0291","article-title":"Premature ovarian failure and ovarian autoimmunity","volume":"18","author":"Hoek","year":"1997","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000152039","article-title":"Recent developments in identifying genetic determinants of premature ovarian failure","volume":"2","author":"Skillern","year":"2008","journal-title":"Sex Dev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1196\/annals.1429.019","article-title":"Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes","volume":"1429","author":"Simpson","year":"2008","journal-title":"Ann NY Acad Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/humupd\/dmi012","article-title":"Premature ovarian failure","volume":"11","author":"Goswami","year":"2005","journal-title":"Hum Reprod."},{"key":"B8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJM198707163170301","article-title":"Familial premature ovarian failure due to an interstitial deletion of the long arm of the 3 chromosome","volume":"317","author":"Krauss","year":"1987","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.7302587","article-title":"Reduction in oocyte number following prenatal exposure to a diet high in galactose","volume":"214","author":"Chen","year":"1981","journal-title":"Science."},{"key":"B10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/humupd\/dml031","article-title":"Pathophysiology of impaired ovarian function in galactosaemia","volume":"12","author":"Forges","year":"2006","journal-title":"Hum Reprod"},{"key":"B11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/humupd\/dmn022","article-title":"GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy","volume":"14","author":"Blumenfeld","year":"2008","journal-title":"Hum Reprod"},{"key":"B12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1530\/REP-09-0567","article-title":"Premature ovarian failure","volume":"140","author":"Shelling","year":"2010","journal-title":"Reproduction."},{"key":"B13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1677\/JME-10-0070","article-title":"Genes involved in human premature ovarian failure","volume":"45","author":"Persani","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1097\/AOG.0b013e3181a66843","article-title":"Premature ovarian failure","volume":"113","author":"Rebar","year":"2009","journal-title":"Obstet Gynecol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(10)60355-8","article-title":"Primary ovarian insufficiency","volume":"376","author":"De Vos","year":"2010","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.tem.2018.03.010","article-title":"Advances in the molecular pathophysiology, genetics, and treatment of primary ovarian insufficiency","volume":"29","author":"Huhtaniemi","year":"2018","journal-title":"Trends Endocrinol Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cge.12921","article-title":"Genetics of primary ovarian insufficiency","volume":"91","author":"Rossetti","year":"2017","journal-title":"Clin Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/humupd\/dmy019","article-title":"Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis","volume":"24","author":"Alviggi","year":"2018","journal-title":"Hum Reprod Update."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.12688\/f1000research.10382.1","article-title":"The novel POSEIDON stratification of 'Low prognosis patients in assisted reproductive technology' and its proposed marker of successful outcome","volume":"5","author":"Humaidan","year":"2016","journal-title":"F1000Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fendo.2019.00281","article-title":"Ovarian reserve markers to identify poor responders in the context of poseidon classification","volume":"10","author":"Grisendi","year":"2019","journal-title":"Front Endocrinol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fendo.2019.00282","article-title":"An observational retrospective cohort trial on 4,828 IVF cycles evaluating different low prognosis patients following the POSEIDON criteria","volume":"10","author":"Levi-Setti","year":"2019","journal-title":"Front Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/humrep\/dez051","article-title":"Cumulative live birth rates in low-prognosis women","volume":"34","author":"Leijdekkers","year":"2019","journal-title":"Hum Reprod"},{"key":"B24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fendo.2018.00589","article-title":"Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker-the follicle-to-oocyte (FOI) index","volume":"9","author":"Alviggi","year":"2018","journal-title":"Front. Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.rbmo.2017.09.016","article-title":"Insights from clinical experience in treating IVF poor responders","volume":"36","author":"Gonda","year":"2018","journal-title":"Reprod Biomed Online."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0207081","DOI":"10.1371\/journal.pone.0207081","article-title":"GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: a retrospective study","volume":"13","author":"Huang","year":"2018","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.fertnstert.2018.08.018","article-title":"Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes","volume":"110","author":"Regan","year":"2018","journal-title":"Fertil Steril."},{"key":"B28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2174\/1389201018666171002132853","article-title":"Ovarian stimulation in poor responders: have we made progress?","volume":"18","author":"Roman","year":"2017","journal-title":"Curr Pharm Biotechnol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3109\/01443615.2014.919997","article-title":"Acupuncture in IVF: A review of current literature","volume":"34","author":"Nandi","year":"2014","journal-title":"J Obstet Gynaecol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.rbmo.2018.12.030","article-title":"Pituitary suppression protocol among Bologna poor responders undergoing ovarian stimulation using corifollitropin alfa: does it play any role?","volume":"38","author":"Err\u00e1zuriz","year":"2019","journal-title":"Reprod Biomed Online."},{"key":"B31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5935\/1518-0557.20180090","article-title":"Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders","volume":"23","author":"F\u00e0bregues","year":"2019","journal-title":"JBRA Assist Reprod."},{"key":"B32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10815-018-1383-2","article-title":"Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials","volume":"36","author":"Noventa","year":"2019","journal-title":"J Assist Reprod Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1530\/JOE-19-0096","article-title":"Androgens and ovarian function: translation from basic discovery research to clinical impact","volume":"242","author":"Walters","year":"2019","journal-title":"J Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1210\/en.2019-00101","article-title":"Physiological and pathological androgen actions in the ovary","volume":"160","author":"Astapova","year":"2019","journal-title":"Endocrinology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4137\/CMRH.S35567","article-title":"Cortisol-Metabolizing enzymes in polycystic ovary syndrome","volume":"10","author":"Blumenfeld","year":"2016","journal-title":"Clin Med Insights Reprod Health."},{"key":"B36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/GCO.0000000000000532","article-title":"Androgen supplementation in assisted reproduction: where are we in 2019?","volume":"31","author":"Montoya-Botero","year":"2019","journal-title":"Curr Opin Obstet Gynecol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1177\/1933719116660849","article-title":"Testosterone for poor ovarian responders: lessons from ovarian physiology","volume":"25","author":"Polyzos","year":"2018","journal-title":"Reprod Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1093\/humrep\/del254","article-title":"Effect of dehydroepiandrosterone on oocyte embryo yields, embryo grade cell number in IVF","volume":"21","author":"Barad","year":"2006","journal-title":"Hum Reprod."},{"key":"B39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10815-007-9178-x","article-title":"Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function","volume":"24","author":"Barad","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.fertnstert.2005.02.049","article-title":"Increased oocyte production after treatment with dehydroepiandrosterone","volume":"84","author":"Barad","year":"2005","journal-title":"Fertil Steril"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/humrep\/15.10.2129","article-title":"Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series","volume":"15","author":"Casson","year":"2000","journal-title":"Hum Reprod"},{"key":"B42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1477-7827-9-67","article-title":"Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1477-7827-7-108","article-title":"Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study","volume":"7","author":"Gleicher","year":"2009","journal-title":"Reprod Biol Endocrinol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1477-7827-8-140","article-title":"Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)","volume":"8","author":"Gleicher","year":"2010","journal-title":"Reprod Biol Endocrinol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.rbmo.2010.04.006","article-title":"Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation","volume":"21","author":"Gleicher","year":"2010","journal-title":"Reprod Biomed"},{"key":"B46","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1477-7827-9-116","article-title":"The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/humrep\/deq220","article-title":"Addition of dehydroepiandrosterone (DHEA) for poor responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study","volume":"25","author":"Wiser","year":"2010","journal-title":"Hum Reprod."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e396","DOI":"10.4236\/ojog.2016.67052","article-title":"Preliminary results of DHEA in poor responders in IVF","volume":"6","author":"Sciard","year":"","journal-title":"Open J Obstet Gynecol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.rbmo.2014.10.005","article-title":"Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study","volume":"30","author":"Vlahos","year":"2015","journal-title":"Reprod Biomed."},{"key":"B50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.fertnstert.2014.03.044","article-title":"A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders","volume":"102","author":"Yeung","year":"2014","journal-title":"Fertil Steril."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e99858","DOI":"10.1371\/journal.pone.0099858","article-title":"Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS ONE."},{"key":"B52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejogrb.2013.11.008","article-title":"Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?","volume":"173","author":"Kara","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/edrv-6-3-400","article-title":"Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function","volume":"6","author":"Adashi","year":"1985","journal-title":"Endocrinol Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1749-6632.1991.tb37920.x","article-title":"Synergistic effect of growth hormone and gonadotropins in achieving conception in \u201cclonidine-negative\u201d patients with unexplained infertility","volume":"626","author":"Blumenfeld","year":"1991","journal-title":"Ann N Y Acad Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/oxfordjournals.humrep.a138483","article-title":"Growth hormone co-treatment for ovulation induction may enhance conception in the co-treatment and succeeding cycles, in clonidine negative but not clonidine positive patients","volume":"9","author":"Blumenfeld","year":"1994","journal-title":"Hum Reprod."},{"key":"B56","first-page":"145","article-title":"The role of growth hormone (GH), GH-receptor and GH-binding protein in reproduction and ovulation induction","volume":"9","author":"Blumenfeld","year":"1996","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/07853899409147899","article-title":"The role of growth hormone in ovulation induction","volume":"26","author":"Blumenfeld","year":"1994","journal-title":"Ann Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0015-0282(16)55610-6","article-title":"The potential relevance of growth hormone to female reproductive physiology and pathophysiology","volume":"59","author":"Katz","year":"1993","journal-title":"Fertil Steril."},{"key":"B59","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0015-0282(16)53277-4","article-title":"Co-treatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial","volume":"53","author":"Homburg","year":"1990","journal-title":"Fertil Sterii."},{"key":"B60","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0015-0282(16)54084-9","article-title":"The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate & human menopausal gonadotropin in women with a poor ovarian response","volume":"55","author":"Ibrahim","year":"1991","journal-title":"Fertil Steril."},{"key":"B61","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000182191","article-title":"Role of growth hormone in infertility","volume":"33","author":"Jacobs","year":"1991","journal-title":"Horm Res."},{"key":"B62","unstructured":"Addition of growth hormone to the stimulation protocol in poor responders-an option for increasing pregnancy rates in failed IVF Cycles-a short communication15\n            KulvinderKK\n            AllahbadiaGN\n            SinghM\n          Open Access J Gynecol.42019"},{"key":"B63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejogrb.2018.06.035","article-title":"The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomized control trial","volume":"228","author":"Dakhly","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/humrep\/10.1.40","article-title":"Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study","volume":"10","author":"Dor","year":"1995","journal-title":"Hum Reprod."},{"key":"B65","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.fertnstert.2015.11.026","article-title":"Does the addition of growth hormone to the in vitro fertilization\/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial","volume":"105","author":"Bassiouny","year":"2016","journal-title":"Fertil Steril."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00404-012-2655-1","article-title":"Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology","volume":"287","author":"Eftekhar","year":"2013","journal-title":"Arch Gynecol Obstet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/09513590.2015.1025378","article-title":"Low-dose growth hormone supplementation increases clinical pregnancy rate in poor responders undergoing in vitro fertilisation","volume":"31","author":"Lattes","year":"2015","journal-title":"Gynecol Endocrinol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0015-0282(16)56825-3","article-title":"Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study","volume":"62","author":"Bergh","year":"1994","journal-title":"Fertil Steril."},{"key":"B69","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.fertnstert.2016.01.022","article-title":"Regimen of ovarian stimulation affects oocyte and therefore embryo quality","volume":"105","author":"Bosch","year":"2016","journal-title":"Fertil Steril."},{"key":"B70","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1701-2163(15)30152-3","article-title":"Growth hormone supplementation in the luteal phase before microdose GnRH agonist flare protocol for in vitro fertilization","volume":"37","author":"Dunne","year":"2015","journal-title":"J Obstet Gynaecol Can."},{"key":"B71","article-title":"A randomized double blind placebo controlled study of recombinant human growth hormone (r~HGH) on live birth rates in women who are poor responders","volume-title":"32nd Annual Meeting of ESHRE","author":"Norman","year":"2016"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1093\/humrep\/dei066","article-title":"Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian costimulation with growth hormone","volume":"20","author":"Tesarik","year":"2005","journal-title":"Hum Reprod."},{"key":"B73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/19396368.2018.1492044","article-title":"Is growth hormone administration essential for in vitro fertilization treatment of female patients with growth hormone deficiency?","volume":"65","author":"Albu","year":"2019","journal-title":"Syst Biol Reprod Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0015-0282(16)60864-6","article-title":"The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotropin in a panhypopituitary patient","volume":"52","author":"Blumenfeld","year":"1989","journal-title":"Fertil Steril."},{"key":"B75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10815-008-9212-7","article-title":"Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial","volume":"25","author":"Kucuk","year":"2008","journal-title":"J Assist Reprod Genet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1210\/jcem.75.5.1430084","article-title":"Growth hormone (GH)-binding protein regulation by estrogen, progesterone, and gonadotropins in human: the effect of ovulation induction with menopausal gonadotropins, GH, and gestation","volume":"75","author":"Blumenfeld","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4103\/ijem.IJEM_101_18","article-title":"Clonidine stimulation test: is single best time point. Convenient yet efficacious?","volume":"22","author":"Thakur","year":"2018","journal-title":"Indian J Endocrinol Metab."},{"key":"B78","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4158\/EP151156.OR","article-title":"Clonidine stimulation test for GH deficiency: a new look at sample timing","volume":"22","author":"Gillis","year":"2016","journal-title":"Endocr Pract."},{"key":"B79","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.fertnstert.2018.03.019","article-title":"Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline","volume":"109","year":"2018","journal-title":"Fertil Steril."},{"key":"B80","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"B81","doi-asserted-by":"publisher","first-page":"89","DOI":"10.23736\/S0026-4784.17.04132-6","article-title":"Prognosis and cost-effectiveness of IVF in poor responders according to the Bologna Criteria","volume":"70","author":"Busnelli","year":"2018","journal-title":"Minerva Ginecol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/humrep\/dew282","article-title":"A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized noninferiority trial","volume":"32","author":"Youssef","year":"2017","journal-title":"Hum Reprod."},{"key":"B83","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod."},{"key":"B84","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.fertnstert.2009.03.027","article-title":"What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?","volume":"94","author":"Berkkanoglu","year":"2010","journal-title":"Fertil Steril."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09513590.2019.1608520","article-title":"Do poor-responder patients undergoing IVF benefit from splitting and increasing the daily gonadotropin dose?","volume":"2019","author":"Ezra","year":"2019","journal-title":"Gynecol Endocrinol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"581451","DOI":"10.1155\/2014\/581451","article-title":"Comparison of IVF outcomes between minimal stimulation and high-dose stimulation for patients with poor ovarian reserve","volume":"2014","author":"Lazer","year":"2014","journal-title":"Int J Reprod Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"372","DOI":"10.23736\/S0026-4784.19.04390-9","article-title":"Double stimulation in the same ovarian cycle (DuoStim) is an intriguing strategy to improve oocyte yield and the number of competent embryos in a short timeframe","volume":"71","author":"Vaiarelli","year":"2019","journal-title":"Minerva Ginecol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0015-0282(16)57722-X","article-title":"Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation","volume":"64","author":"van Kasteren","year":"1995","journal-title":"Fertil Steril"},{"key":"B89","first-page":"71","article-title":"Pharmacological options in resistant ovary syndrome and premature ovarian failure","volume":"33","author":"Check","year":"2006","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B90","first-page":"10","article-title":"Ovulation induction and pregnancy in a woman with premature menopause following gonadotropin suppression with the gonadotropin releasing hormone antagonist, cetrorelix - a case report","volume":"35","author":"Check","year":"2008","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B91","first-page":"13","article-title":"Successful pregnancy with spontaneous ovulation in a woman with apparent premature ovarian failure who failed to conceive despite four transfers of embryos derived from donated oocytes","volume":"33","author":"Check","year":"2006","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B92","first-page":"299","article-title":"Pregnancy despite imminent ovarian failure and extremely high endogenous gonadotropins and therapeutic strategies: case report and review","volume":"31","author":"Check","year":"2004","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B93","first-page":"97","article-title":"Successful pregnancy following in vitro fertilization-embryo transfer despite imminent ovarian failure","volume":"27","author":"Check","year":"2000","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B94","first-page":"195","article-title":"Viable pregnancy in a woman with premature ovarian failure treated with gonadotropin suppression and human menopausal gonadotropin stimulation. A case report","volume":"36","author":"Check","year":"1991","journal-title":"J Reprod Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0002-9378(89)90458-4","article-title":"Ovulation induction and pregnancy with an estrogen-gonadotropin stimulation technique in a menopausal woman with marked hypoplastic ovaries","volume":"160","author":"Check","year":"1989","journal-title":"Am J Obstet Gynecol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/0002-9378(89)90100-2","article-title":"Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy","volume":"160","author":"Check","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1472-6483(10)60711-0","article-title":"Induction of ovulation in idiopathic premature ovarian failure: a randomized double-blind trial","volume":"15","author":"Badawy","year":"2007","journal-title":"Reprod Biomed."},{"key":"B98","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12958-018-0343-0","article-title":"Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial","volume":"16","author":"Xu","year":"2018","journal-title":"Reprod Biol Endocrinol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/biof.5520180211","article-title":"Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure","volume":"18","author":"Rosenfeldt","year":"2003","journal-title":"Biofactors."},{"key":"B100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.fertnstert.2003.05.009","article-title":"Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study","volume":"81","author":"Balercia","year":"2004","journal-title":"Fertil Steril."},{"key":"B101","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11255-011-0081-0","article-title":"The effect of coenzyme Q10 supplementation on partner pregnancy rate in infertile men with idiopathic oligo asthenoteratozoospermia: an open-label prospective study","volume":"44","author":"Reza Safarinejad","year":"2012","journal-title":"Int Urol Nephrol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/acel.12368","article-title":"Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging","volume":"14","author":"Ben-Meir","year":"2015","journal-title":"Aging Cell."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10815-016-0751-z","article-title":"Can coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage?","volume":"33","author":"Ozcan","year":"2016","journal-title":"J Assist Reprod Genet."},{"key":"B104","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ymgme.2003.12.008","article-title":"Cofactor treatment improves ATP synthetic capacity in women with oxidative phosphorylation disorders","volume":"81","author":"Marriage","year":"2004","journal-title":"Mol Genet Metab."},{"key":"B105","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.rbmo.2014.03.011","article-title":"Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome","volume":"29","author":"El Refaeey","year":"2014","journal-title":"Reprod BioMed Online."},{"key":"B106","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4137\/CMRH.S14681","article-title":"Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatment","volume":"8","author":"Bentov","year":"2014","journal-title":"Clin Med Insights Reprod Health."},{"key":"B107","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12906-019-2523-7","article-title":"The effects of acupuncture on pregnancy outcomes of in vitro fertilization: a systematic review and meta-analysis","volume":"19","author":"Xie","year":"2019","journal-title":"BMC Complement Altern Med."},{"key":"B108","first-page":"9","article-title":"The holistic health care of couples undergoing IVF\/ET","volume":"102","author":"Kuczynski","year":"1989","journal-title":"Midwives Chron."},{"key":"B109","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.explore.2011.02.001","article-title":"Complementary therapy systems and their integrative evaluation","volume":"7","author":"Kienle","year":"2011","journal-title":"Explore"},{"key":"B110","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1472-6882-9-52","article-title":"Australian women's use of complementary and alternative medicines to enhance fertility: exploring the experiences of women and practitioners","volume":"9","author":"Rayner","year":"2009","journal-title":"BMC Complement Altern Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1089\/acm.2010.0435","article-title":"Women's use of complementary alternative medicine for fertility enhancement: a review of the literature","volume":"17","author":"Rayner","year":"2011","journal-title":"J Altern Complement Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.3889\/oamjms.2019.825","article-title":"Live birth rates in poor responders' group after previous treatment with autologous platelet-rich plasma and low dose ovarian stimulation compared with poor responders used only low dose ovarian stimulation before in vitro fertilization","volume":"7","author":"Stojkovska","year":"2019","journal-title":"Open Access Maced J Med Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000491697","article-title":"A case series on platelet-rich plasma revolutionary management of poor responder patients","volume":"84","author":"Sfakianoudis","year":"2019","journal-title":"Gynecol Obstet Invest."},{"key":"B114","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.rbmo.2019.09.007","article-title":"Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve","volume":"40","author":"Kawamura","year":"2020","journal-title":"Reprod Biomed Online."},{"key":"B115","doi-asserted-by":"publisher","first-page":"17474","DOI":"10.1073\/pnas.1312830110","article-title":"Hippo signaling disruption and akt stimulation of ovarian follicles for infertility treatment","volume":"110","author":"Kawamura","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B116","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/humrep\/deu353","article-title":"Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency","volume":"30","author":"Suzuki","year":"2015","journal-title":"Hum Reprod."},{"key":"B117","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1210\/jc.2016-1589","article-title":"In vitro activation of follicles and fresh tissue auto-transplantation in primary ovarian insufficiency patients","volume":"101","author":"Zhai","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9010200","article-title":"Crosstalk between PTEN\/PI3K\/Akt signalling and DNA damage in the oocyte: implications for primordial follicle activation","volume":"9","author":"Maidarti","year":"2020","journal-title":"Oocyte Quality Ageing Cells."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s10815-013-0052-8","article-title":"Attempted application of bioengineered\/biosynthetic supporting matrices with phosphatidylinositol-trisphosphate enhancing substances to organ culture of human primordial follicles","volume":"30","author":"Lerer-Serfaty","year":"2013","journal-title":"J Assist Reprod Genet."},{"key":"B120","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/molehr\/gau037","article-title":"Inhibition of phosphatase and tensin homologue (pten) in human ovary in vitro results in increased activation of primordial follicles but compromises development of growing follicles","volume":"20","author":"McLaughlin","year":"2014","journal-title":"Mol Hum Reprod."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/humrep\/dey250","article-title":"Dynamics of pi3k and hippo signaling pathways during in vitro human follicle activation","volume":"33","author":"Grosbois","year":"2018","journal-title":"Hum Reprod."},{"key":"B122","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/GCO.0000000000000452","article-title":"What is new in the management of poor ovarian response in IVF?","volume":"30","author":"Vaiarelli","year":"2018","journal-title":"Curr Opin Obstet Gynecol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.4161\/cc.26358","article-title":"Ovarian follicle burnout: A universal phenomenon?","volume":"12","author":"Roness","year":"2013","journal-title":"Cell Cycle."},{"key":"B124","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1530\/REP-07-0131","article-title":"Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice","volume":"134","author":"Dolmans","year":"2007","journal-title":"Reproduction."},{"key":"B125","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10815-017-1079-z","article-title":"Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation","volume":"35","author":"Gavish","year":"2018","journal-title":"J Assist Reprod Genet."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T04:18:35Z","timestamp":1587097115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":125,"alternative-id":["10.3389\/fendo.2020.00192"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00192","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,17]]},"article-number":"192"}}